Figure 1
From: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases
Flow chart of the study population. ICI = immune checkpoint inhibitor; BM = Brain Metastases; LCBM = lung cancer brain metastases.
Figure 1 | Scientific Reports
